NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow) 7. NEVER be a blind follower. LASTLY, ...
IamBadNewz
:
@Jaguar8 Been waiting (im)patiently for a pop on CGTX given the recent conference and news of insider buying but price hasn’t reacted. Your thoughts?
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow) 7. NEVER be a blind follower. LASTLY, If...
FernandoTrades
:
not trying to post my own watchlist or anything just looking for advise. All these stocks have there earning reports come out tmr and I was wondering if you think there good or not.
Jaguar8
OP
HannChau
:
If Trump imposes tariffs or restrictions on steel and aluminum imports, U.S. steel stocks could see a short-term boost as domestic producers benefit from reduced foreign competition. Higher import costs might lead to increased demand for American-made steel, potentially driving up prices and improving profit margins forcompanies like NUE, X, and CLF. However, industries reliant on steel, such as automotive and construction, could face higher costs, which might eventually reduce demand. Investors should watch for potential retaliation from trade partners, as countermeasures could offset some gains.
$Intelligent Bio Solutions (INBS.US)$great long term as the company moves into the US market this year. Short term-resistance is at 2.19 with breakout at 2.48. Support is at 1.85. No short shares available. Borrow rate increasing. $Eyenovia (EYEN.US)$Volume has started to bottom out. Borrow rate increasing. Breakout is more than likely going to happen after mid-week. Spent Friday mostly in the 1.81-1.83 range which should have created a support level. Reversal to 3.60 is pr...
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow...
59
8
3
Report
HannChau
:
I will not be silent stalker but always will be voice out 'stalker'
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow) 7. NEVER be a blind follower. LASTLY, ...
56
13
1
Report
74537207
:
thank you very much , I am starting to miss your 'mega' picks a bit
$Eyenovia (EYEN.US)$Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device GlobeNewswire· 6 mins ago Eyenovia plans to submit for U.S. device regulatory approval in Q4 of this year, marking a key step toward commercialization
$Eyenovia (EYEN.US)$ Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device Wednesday, 5th February at 7:00 am NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet® device, today announces recent progress on the development of its user-filled spray dispenser. "Millions of consumers have difficulty with traditional eye...
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow) 7. NEVER be a blind follower. LASTLY,...
Arrayfunction
:
Do you know much about $Nexalin Technology (NXL.US)$ 's tech? It's one of those I wish would work out but I am getting too many red flags. The tech just sounds like deep brain stimulation - which has never been shown to be effective enough for indication. The head scratcher about why a 2mmHg decrease in BP is a success when that's within margin of error for most devices. Also, it didn't reference that norepinephrine and dopamine are given in all kinds of MDD / chronic pain situations which will raise BP. I could certainly use an anti-hypertensive. My MAP tends to chill at about 115mmHg these days. But don't want to get my hopes up
kingrotch : thank you for your work![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
真名有晨 : Thank you very much
Please take care and rest.
iluvpoptarts : sry doc. I'm too busy counting the money your making me too look. muha
IamBadNewz : @Jaguar8 Been waiting (im)patiently for a pop on CGTX given the recent conference and news of insider buying but price hasn’t reacted. Your thoughts?
Jaguar8 OP IamBadNewz : You have to be patient
View more comments...